Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST Biotherapeutics, Inc. (1STBIO), a...
Read More
Recent events support advancements and programs for local cancer patients April 14, 2025 – The...
Read More
The Mental Health Awareness Walk, a celebration of hope, continues to grow each year, hitting a...
Read More
Children’s Miracle Network Hospitals presented on April 9, the national recognition highlights...
Read More
Groundbreaking treatment enhances the immune system’s ability to fight cancer April 15, 2025 –...
Read More
